PL
PL · PL · PL-100463322
Xevudy
ATC J06BD05
Last synced from URPL (Poland) on
Identification
ManufacturerGlaxoSmithKline Trading Services Limited
CountryPL (PL)
ATC codeJ06BD05
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin05909991474980
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909991474980 ¦ Rp ¦ EU/1/21/1562/001 ¦ 143375\n1 fiol.",
"substance": "Sotrovimabum 500 mg",
"common_name": "Sotrovimabum",
"pl_product_id": "100463322",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code J06BD05.
- GBSotrovimab 500mg/8ml solution for infusion vialsGlaxoSmithKline UK Ltd
- FIXevudyGlaxoSmithKline Trading Services Limited
- DKXevudyGlaxoSmithKline Trading Services Limited
- BEXevudy 500 mgGlaxoSmithKline Trading Services
- 🇪🇸XEVUDY 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONGlaxosmithkline Trading Services Limited
- 🇫🇷XEVUDY 500 mg, solution à diluer pour perfusionGLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- GBXevudy 500mg/8ml concentrate for solution for infusion vialsGlaxoSmithKline UK Ltd
Access this data programmatically
Query Xevudy and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.